Herantis Pharma Oyj (HRTIS) — Net Asset Quality Index
Herantis Pharma Oyj (HRTIS) has a Net Asset Quality Index of 34.2% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €5.11 Million minus total liabilities of €3.36 Million yields net assets of €1.75 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are Herantis Pharma Oyj's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Herantis Pharma Oyj Net Asset Quality Index Over Time (2011–2024)
This chart shows how Herantis Pharma Oyj's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of June 2025, the index stands at 34.2%, representing net assets of €1.75 Million against total assets of €5.11 Million EUR. See how liquid is Herantis Pharma Oyj's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Herantis Pharma Oyj (2011–2024)
The table below presents the year-by-year Net Asset Quality Index for Herantis Pharma Oyj from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see HRTIS market cap.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | -9.5% | €-243.00K | €2.57 Million | €2.81 Million | ▼ -79.5 pp |
| 2023 | 70.1% | €4.73 Million | €6.75 Million | €2.02 Million | ▲ +71.0 pp |
| 2022 | -1.0% | €-60.28K | €6.23 Million | €6.29 Million | ▼ -9.0 pp |
| 2021 | 8.0% | €554.30K | €6.92 Million | €6.36 Million | ▼ -38.2 pp |
| 2020 | 46.2% | €7.59 Million | €16.42 Million | €8.83 Million | ▲ +29.5 pp |
| 2019 | 16.7% | €1.85 Million | €11.07 Million | €9.22 Million | ▲ +18.0 pp |
| 2018 | -1.2% | €-89.29K | €7.15 Million | €7.24 Million | ▼ -36.6 pp |
| 2017 | 35.3% | €4.09 Million | €11.57 Million | €7.48 Million | ▲ +19.9 pp |
| 2016 | 15.4% | €1.57 Million | €10.21 Million | €8.63 Million | ▼ -27.2 pp |
| 2015 | 42.6% | €6.00 Million | €14.09 Million | €8.09 Million | ▼ -31.1 pp |
| 2014 | 73.6% | €21.72 Million | €29.49 Million | €7.77 Million | ▲ +69.1 pp |
| 2013 | 4.5% | €120.00K | €2.64 Million | €2.52 Million | ▲ +4.7 pp |
| 2012 | -0.2% | €-3.37K | €2.21 Million | €2.21 Million | ▲ +186.4 pp |
| 2011 | -186.5% | €-1.25 Million | €670.13K | €1.92 Million | — |